Literature DB >> 1827065

Hepatopoietins A and B and hepatocyte growth.

G K Michalopoulos1, R Zarnegar, K Houck, P Pediaditakis.   

Abstract

Serum from control or partially hepatectomized rats contains only two substances associated with stimulation of DNA synthesis in primary cultures of hepatocytes in serum free conditions. Hepatopoietin A is a large (105,000 kDa in monomeric form) heparin binding growth factor that is a heterodimer of two polypeptide chains (70,000 and 35,000 kDa). Another heparin binding growth factor, acidic FGF, also stimulates hepatocyte DNA synthesis but at a level comparable to half that of HPTA. These findings, along with recent observations of stimulation of liver growth and hepatoma formation in mice transgenic for the tat gene of the AIDS virus and overproducers of the heparin binding factor hst/KS3, raise the issue of the overall importance of different heparin binding growth factors in the control of hepatic growth regulation. Hepatopoietin B is a glycolipid that also acts as a complete hepatocytic mitogen. The role of the above substances as well as the role of norepinephrine, acting as a mitogenic trigger for stimulation of the rapid early phenomena associated with liver regeneration, is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827065     DOI: 10.1007/bf01297038

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  HETEROTOPIC PARTIAL AUTOTRANSPLANTATION OF RAT LIVER: TECHNIC AND DEMONSTRATION OF STRUCTURE AND FUNCTION OF THE GRAFT.

Authors:  J W GRISHAM; G F LEONG; B V HOLE
Journal:  Cancer Res       Date:  1964-09       Impact factor: 12.701

2.  Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver.

Authors:  A D Burt; D Tiniakos; R N MacSween; M R Griffiths; E Wisse; J M Polak
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

3.  Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells.

Authors:  N C Luetteke; G K Michalopoulos
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

4.  Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures.

Authors:  T Nakamura; H Teramoto; A Ichihara
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Incorporation of pyrimidine deoxyribonucleosides into liver lipids and other components.

Authors:  W C Schneider; A E Greco
Journal:  Biochim Biophys Acta       Date:  1971-02-11

6.  Control of hepatocyte replication by two serum factors.

Authors:  G Michalopoulos; K A Houck; M L Dolan; N C Leutteke
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

7.  Purification and subunit structure of hepatocyte growth factor from rat platelets.

Authors:  T Nakamura; K Nawa; A Ichihara; N Kaise; T Nishino
Journal:  FEBS Lett       Date:  1987-11-30       Impact factor: 4.124

8.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

9.  Regeneration of rat liver: transfer of humoral agent by cross circulation.

Authors:  F L Moolten; N L Bucher
Journal:  Science       Date:  1967-10-13       Impact factor: 47.728

10.  Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.

Authors:  H Tsubouchi; S Hirono; E Gohda; H Nakayama; K Takahashi; O Sakiyama; H Miyazaki; J Sugihara; E Tomita; Y Muto
Journal:  Hepatology       Date:  1989-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.